Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Equity: 2018-2025

Historic Return on Equity for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to 0.27%.

  • Puma Biotechnology's Return on Equity fell 12.00% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of 0.32% for FY2024, which is 26.00% down from last year.
  • Per Puma Biotechnology's latest filing, its Return on Equity stood at 0.27% for Q3 2025, which was down 33.69% from 0.41% recorded in Q2 2025.
  • Puma Biotechnology's 5-year Return on Equity high stood at 4.34% for Q4 2021, and its period low was -20.84% during Q1 2022.
  • Moreover, its 3-year median value for Return on Equity was 0.28% (2024), whereas its average is 0.26%.
  • As far as peak fluctuations go, Puma Biotechnology's Return on Equity crashed by 1,578bps in 2022, and later skyrocketed by 2,104bps in 2023.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Return on Equity stood at 4.34% in 2021, then tumbled by 434bps to 0.00% in 2022, then surged by 47bps to 0.47% in 2023, then declined by 18bps to 0.28% in 2024, then dropped by 12bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q3 2025, 0.41% for Q2 2025, and 0.33% during Q1 2025.